2022
DOI: 10.3390/molecules27154886
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of New Inhibitors of eEF2K from Traditional Chinese Medicine Based on In Silico Screening and In Vitro Experimental Validation

Abstract: Eukaryotic elongation factor 2 kinase (eEF2K) is a highly conserved α kinase and is increasingly considered as an attractive therapeutic target for cancer as well as other diseases. However, so far, no selective and potent inhibitors of eEF2K have been identified. In this study, pharmacophore screening, homology modeling, and molecular docking methods were adopted to screen novel inhibitor hits of eEF2K from the traditional Chinese medicine database (TCMD), and then cytotoxicity assay and western blotting were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…Western blotting was performed according to previously described methods with some modifications ( Fu et al., 2022 ). Briefly, cells or tissue powders were lysed using RIPA lysis buffer (IN-WB001, Invent, Plymouth, USA) with 1 mmol/L PMSF (P0100, Solarbio Technology Co., Beijing, China).…”
Section: Methodsmentioning
confidence: 99%
“…Western blotting was performed according to previously described methods with some modifications ( Fu et al., 2022 ). Briefly, cells or tissue powders were lysed using RIPA lysis buffer (IN-WB001, Invent, Plymouth, USA) with 1 mmol/L PMSF (P0100, Solarbio Technology Co., Beijing, China).…”
Section: Methodsmentioning
confidence: 99%
“…Western blot analysis was performed as previously described [ 18 ]. Briefly, frozen liver and adipose tissues from 3 chickens slaughtered per group were lysed using RIPA lysis buffer (IN-WB001, Invent, Plymouth, MA, USA) with 1 mM PMSF (P0100, Solarbio Technology Co., Beijing, China).…”
Section: Methodsmentioning
confidence: 99%
“…Though not encompassing, we describe a general workflow for structure-based drug design and the optimization process ( Figure 3 ). A recent example of drug discovery targeting eEF2K, which used a computational screening pipeline with a database of traditional Chinese medicines, identified several antitumor chemicals with low cytotoxicity [ 67 ].…”
Section: Computational Aids For Eef2k and General Drug Discoverymentioning
confidence: 99%